PICK A TIME SLOT
₹ Price not available
Mukundapur
Book an appointment for Consultation
₹ Price not available
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. Dipanjana Datta is a BGCI Level II certified Genetic Counselor and has 16 years of experience in the field of human genetics. She is the West Bengal Coordinator for the Organization of Rare Disease India. She currently is also nominated as an executive member for the Bengal chapter of the Society of Fetal Medicine. Dr. Datta did her M.Sc in Biochemistry from Calcutta University and completed her PhD from the Indian Institute of Chemical Biology, Kolkata ( IICB). She was a post-doctoral fellow at Virginia Commonwealth University (VCU). She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, Kidney International etc. Dr Datta also holds a patent on in discovery and validation of New Biomarkers for metastasis in Head & Neck Cancer along with other members. She also holds a position as a principal for a diploma course in Early intervention in neurodevelopmental disorders. She is the foremost Genetics Doctor in Kolkata.
- Genetics
- Prenatal
- Paediatrics
- Preconception
- Infertility
- Neurological mental health
- Oncology
- Endocrinology
- Nephrology
- Cardiology
- American Society for Human Genetics (ASHG) ( Student member)
- Indian Society for Human Genetics (ISHG)
- Calcutta consortium of human genetics (CCHuGe)
- Society for Biological Chemists (SBC)
- The Indian Immunological Society (IIS)
- Indian Genome Variation Consortium
- English
- Hindi
- Bengali
- Association of IL1B with Helicobacter pylori-induced duodenal ulcer in eastern Indian population and elucidation of the signalling pathways of IL1B that regulate gastric acid secretion.
- Identification and elucidation of mu -opioid receptors that respond to morphine in the gut; their splicing isoforms and the role of these splice variants in developing morphine tolerance in the gut, the effect of HIV tat on myenteric neurons.
- Biomarker discovery for predicting metastasis in oral cancer in the Indian population
- Indian genome variation database, idiopathic spontaneous abortions,
- Y chromosome microdeletions in the Indian population, Cystic fibrosis, Prenatal genetics, risk prediction etc.
- She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, etc
Overview
Field of Expertise
Fellowship & Membership
Languages Spoken
Talks & Publications
- American Society for Human Genetics (ASHG) ( Student member)
- Indian Society for Human Genetics (ISHG)
- Calcutta consortium of human genetics (CCHuGe)
- Society for Biological Chemists (SBC)
- The Indian Immunological Society (IIS)
- Indian Genome Variation Consortium
Dr. Dipanjana Datta is a BGCI Level II certified Genetic Counselor and has 16 years of experience in the field of human genetics. She is the West Bengal Coordinator for the Organization of Rare Disease India. She currently is also nominated as an executive member for the Bengal chapter of the Society of Fetal Medicine. Dr. Datta did her M.Sc in Biochemistry from Calcutta University and completed her PhD from the Indian Institute of Chemical Biology, Kolkata ( IICB). She was a post-doctoral fellow at Virginia Commonwealth University (VCU). She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, Kidney International etc. Dr Datta also holds a patent on in discovery and validation of New Biomarkers for metastasis in Head & Neck Cancer along with other members. She also holds a position as a principal for a diploma course in Early intervention in neurodevelopmental disorders. She is the foremost Genetics Doctor in Kolkata.
- Genetics
- Prenatal
- Paediatrics
- Preconception
- Infertility
- Neurological mental health
- Oncology
- Endocrinology
- Nephrology
- Cardiology
- English
- Hindi
- Bengali
- Association of IL1B with Helicobacter pylori-induced duodenal ulcer in eastern Indian population and elucidation of the signalling pathways of IL1B that regulate gastric acid secretion.
- Identification and elucidation of mu -opioid receptors that respond to morphine in the gut; their splicing isoforms and the role of these splice variants in developing morphine tolerance in the gut, the effect of HIV tat on myenteric neurons.
- Biomarker discovery for predicting metastasis in oral cancer in the Indian population
- Indian genome variation database, idiopathic spontaneous abortions,
- Y chromosome microdeletions in the Indian population, Cystic fibrosis, Prenatal genetics, risk prediction etc.
- She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, etc
Fellowship & Membership
Overview
Field of Expertise
Languages Spoken
Talks & Publications
- English
- Hindi
- Bengali
Dr. Dipanjana Datta is a BGCI Level II certified Genetic Counselor and has 16 years of experience in the field of human genetics. She is the West Bengal Coordinator for the Organization of Rare Disease India. She currently is also nominated as an executive member for the Bengal chapter of the Society of Fetal Medicine. Dr. Datta did her M.Sc in Biochemistry from Calcutta University and completed her PhD from the Indian Institute of Chemical Biology, Kolkata ( IICB). She was a post-doctoral fellow at Virginia Commonwealth University (VCU). She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, Kidney International etc. Dr Datta also holds a patent on in discovery and validation of New Biomarkers for metastasis in Head & Neck Cancer along with other members. She also holds a position as a principal for a diploma course in Early intervention in neurodevelopmental disorders. She is the foremost Genetics Doctor in Kolkata.
- American Society for Human Genetics (ASHG) ( Student member)
- Indian Society for Human Genetics (ISHG)
- Calcutta consortium of human genetics (CCHuGe)
- Society for Biological Chemists (SBC)
- The Indian Immunological Society (IIS)
- Indian Genome Variation Consortium
- Genetics
- Prenatal
- Paediatrics
- Preconception
- Infertility
- Neurological mental health
- Oncology
- Endocrinology
- Nephrology
- Cardiology
- Association of IL1B with Helicobacter pylori-induced duodenal ulcer in eastern Indian population and elucidation of the signalling pathways of IL1B that regulate gastric acid secretion.
- Identification and elucidation of mu -opioid receptors that respond to morphine in the gut; their splicing isoforms and the role of these splice variants in developing morphine tolerance in the gut, the effect of HIV tat on myenteric neurons.
- Biomarker discovery for predicting metastasis in oral cancer in the Indian population
- Indian genome variation database, idiopathic spontaneous abortions,
- Y chromosome microdeletions in the Indian population, Cystic fibrosis, Prenatal genetics, risk prediction etc.
- She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, etc
Languages Spoken
Overview
Fellowship & Membership
Field of Expertise
Talks & Publications
- Genetics
- Prenatal
- Paediatrics
- Preconception
- Infertility
- Neurological mental health
- Oncology
- Endocrinology
- Nephrology
- Cardiology
- American Society for Human Genetics (ASHG) ( Student member)
- Indian Society for Human Genetics (ISHG)
- Calcutta consortium of human genetics (CCHuGe)
- Society for Biological Chemists (SBC)
- The Indian Immunological Society (IIS)
- Indian Genome Variation Consortium
- English
- Hindi
- Bengali
- Association of IL1B with Helicobacter pylori-induced duodenal ulcer in eastern Indian population and elucidation of the signalling pathways of IL1B that regulate gastric acid secretion.
- Identification and elucidation of mu -opioid receptors that respond to morphine in the gut; their splicing isoforms and the role of these splice variants in developing morphine tolerance in the gut, the effect of HIV tat on myenteric neurons.
- Biomarker discovery for predicting metastasis in oral cancer in the Indian population
- Indian genome variation database, idiopathic spontaneous abortions,
- Y chromosome microdeletions in the Indian population, Cystic fibrosis, Prenatal genetics, risk prediction etc.
- She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, etc
Dr. Dipanjana Datta is a BGCI Level II certified Genetic Counselor and has 16 years of experience in the field of human genetics. She is the West Bengal Coordinator for the Organization of Rare Disease India. She currently is also nominated as an executive member for the Bengal chapter of the Society of Fetal Medicine. Dr. Datta did her M.Sc in Biochemistry from Calcutta University and completed her PhD from the Indian Institute of Chemical Biology, Kolkata ( IICB). She was a post-doctoral fellow at Virginia Commonwealth University (VCU). She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, Kidney International etc. Dr Datta also holds a patent on in discovery and validation of New Biomarkers for metastasis in Head & Neck Cancer along with other members. She also holds a position as a principal for a diploma course in Early intervention in neurodevelopmental disorders. She is the foremost Genetics Doctor in Kolkata.
Field of Expertise
Fellowship & Membership
Languages Spoken
Talks & Publications
Overview
- Association of IL1B with Helicobacter pylori-induced duodenal ulcer in eastern Indian population and elucidation of the signalling pathways of IL1B that regulate gastric acid secretion.
- Identification and elucidation of mu -opioid receptors that respond to morphine in the gut; their splicing isoforms and the role of these splice variants in developing morphine tolerance in the gut, the effect of HIV tat on myenteric neurons.
- Biomarker discovery for predicting metastasis in oral cancer in the Indian population
- Indian genome variation database, idiopathic spontaneous abortions,
- Y chromosome microdeletions in the Indian population, Cystic fibrosis, Prenatal genetics, risk prediction etc.
- She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, etc
Dr. Dipanjana Datta is a BGCI Level II certified Genetic Counselor and has 16 years of experience in the field of human genetics. She is the West Bengal Coordinator for the Organization of Rare Disease India. She currently is also nominated as an executive member for the Bengal chapter of the Society of Fetal Medicine. Dr. Datta did her M.Sc in Biochemistry from Calcutta University and completed her PhD from the Indian Institute of Chemical Biology, Kolkata ( IICB). She was a post-doctoral fellow at Virginia Commonwealth University (VCU). She has published in numerous international journals of repute like PNAS, Journal of Neurology, Plos One, International Journal of Gastroenterology, Kidney International etc. Dr Datta also holds a patent on in discovery and validation of New Biomarkers for metastasis in Head & Neck Cancer along with other members. She also holds a position as a principal for a diploma course in Early intervention in neurodevelopmental disorders. She is the foremost Genetics Doctor in Kolkata.
- American Society for Human Genetics (ASHG) ( Student member)
- Indian Society for Human Genetics (ISHG)
- Calcutta consortium of human genetics (CCHuGe)
- Society for Biological Chemists (SBC)
- The Indian Immunological Society (IIS)
- Indian Genome Variation Consortium
- Genetics
- Prenatal
- Paediatrics
- Preconception
- Infertility
- Neurological mental health
- Oncology
- Endocrinology
- Nephrology
- Cardiology
- English
- Hindi
- Bengali
Talks & Publications
Overview
Fellowship & Membership
Field of Expertise
Languages Spoken
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
